Therefore, we also deduced the nuclear enrichment of cardiac hypertrophy associated transcription factors and noticed there was increased nuclear enrichment of GATA4 and NFATc3 with β-catenin upon Ang-II treatment in a dose-dependent assessment. The gene discussed is NFATC3; the disease is cardiac hypertrophy.